Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetically engineered antibodies.

G P Moore1

  • 1Integrated Genetics, Inc., Framingham, MA 01701.

Clinical Chemistry
|September 1, 1989
PubMed
Summary
This summary is machine-generated.

Advancements in genetic engineering enable custom antibody design and production. Novel techniques allow precise control over antibody sequences for enhanced therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the impact of CPAP weaning procedures on total days on nasal CPAP: A retrospective chart review.

Journal of neonatal-perinatal medicine·2021
Same author

Worsening anemia associated with volvulus in a stable neonate with intestinal obstruction.

Journal of neonatal-perinatal medicine·2018
Same author

Field testing of decision coaching with a decision aid for parents facing extreme prematurity.

Journal of perinatology : official journal of the California Perinatal Association·2017
Same author

Shared decision making for infants born at the threshold of viability: a prognosis-based guideline.

Journal of perinatology : official journal of the California Perinatal Association·2016
Same author

Interspike interval fluctuations in aplysia pacemaker neurons.

Biophysical journal·2009
Same author

Tyr-TGFalpha transgenic mice develop ocular melanocytic lesions.

Melanoma research·2002
Same journal

Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

Clinical chemistry·2026
Same journal

Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

Clinical chemistry·2026
Same journal

TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

Clinical chemistry·2026
Same journal

Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

Clinical chemistry·2026
Same journal

Editor's Note: Circulating Proteolytic Products of Carboxypeptidase N for Early Detection of Breast Cancer.

Clinical chemistry·2026
Same journal

In Reply to Reflexing NT-proBNP for sFlt-1/PlGF Ratios That Fall into the Measurement Uncertainty for Preeclampsia Risk Classification.

Clinical chemistry·2026
See all related articles

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Immunology

Background:

  • Genetic engineering technologies for antibody production are rapidly advancing.
  • The utility of novel engineered antibodies is under active investigation.
  • Current methods allow for in vitro manipulation and expression of antibody genes.

Purpose of the Study:

  • To explore the evolving technologies for genetic antibody engineering.
  • To highlight recent significant advances in antibody gene manipulation and synthesis.
  • To discuss the creation of novel antibody reagents with enhanced properties.

Main Methods:

  • Cloning of antibody genes from genomic libraries.
  • In vitro manipulation and mutagenesis of antibody genes.

Related Experiment Videos

  • De novo chemical synthesis of antibody genes for complete sequence control.

    • Main Results:

    • Significant improvements achieved at each stage of antibody engineering.
    • Rapid sequencing techniques enable more specific screening.
    • De novo synthesis allows for the production of antibodies with any desired configuration.

    Conclusions:

    • Engineered antibodies offer enhanced immunocompatibility through human sequence replacement.
    • New reagents can be designed to switch immunoglobulin class.
    • The technology facilitates the creation of custom antibody molecules for diverse applications.